SEC Form 4 · accession 0001196862-15-000001
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Randall E Woods
Director
Period of report
Mar 30, 2015
Accepted (ET)
Apr 1, 2015 · 6:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 30, 2015 | M | 40,268 | $1.49 | A | 85,380 | D | |
| Common Stock | Mar 30, 2015 | M | 36,000 | $1.27 | A | 121,380 | D | |
| Common StockF1 | Mar 30, 2015 | S | 76,268 | $4.4875 | D | 45,112 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.49 | Mar 30, 2015 | M | 40,268 | D | — | Mar 15, 2021 | Common Stock | 40,268 | 12,000 | D |
| Stock Option (right to buy)F3 | $1.27 | Mar 30, 2015 | M | 36,000 | D | — | Jun 13, 2021 | Common Stock | 36,000 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $4.48 and $4.50 per share, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The options vested in 12 equal monthly installments over one year beginning on April 15, 2011, and became exercisable once vested.
- F3The options vested in 12 equal monthly installments over one year beginning on July 13, 2011, and became exercisable once vested.